Sinovac Biotech Co., Ltd

This study tests a new vaccine to protect babies aged 6 to 11 months from meningitis caused by four types of meningococcal bacteria. About 1040 healthy infants will receive either the new vaccine or an existing one to compare safety and immune response. The goal is to see if the …

This early-stage trial tests the safety of a new RSV mRNA vaccine in 60 healthy adults aged 18 and older. Participants will receive different doses of the vaccine or a placebo to check for side effects. The goal is to see if the vaccine is safe enough for further testing.

This study checks whether three different batches of a rabies vaccine made by Sinovac produce the same immune response in healthy adults aged 18 to 45. About 912 volunteers will receive one of the batches, and researchers will measure antibody levels and watch for side effects. T…